Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.6K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.6K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

648
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
648
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.1K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.1K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

546
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
546

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention.

American journal of respiratory and critical care medicine·2001
Same author

Nosocomial pneumonia: trying to make sense of the literature.

Postgraduate medicine·1996
Same author

Occupational exposure to tuberculosis: risk and consequences.

Chest·1994
Same author

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.

American journal of respiratory and critical care medicine·1994
Same author

The tuberculin skin test.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1993
Same author

The treatment of tuberculosis.

The Medical clinics of North America·1993
Same journal

COVID-19 pandemic-related changes in utilization of telehealth and treatment overall for alcohol use problems.

Alcoholism, clinical and experimental research·2022
Same journal

The relationship between fathers' heavy episodic drinking and fathering involvement in five Asia-Pacific countries: An individual participant data meta-analysis.

Alcoholism, clinical and experimental research·2022
Same journal

Screening for hazardous alcohol use in the Emergency Department: Comparison of phosphatidylethanol with the Alcohol Use Disorders Identification Test and the Timeline Follow-back.

Alcoholism, clinical and experimental research·2022
Same journal

Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels.

Alcoholism, clinical and experimental research·2022
Same journal

College students' virtual and in-person drinking contexts during the COVID-19 pandemic.

Alcoholism, clinical and experimental research·2022
Same journal

Does state repeal of alcohol exclusion laws increase problem drinking?

Alcoholism, clinical and experimental research·2022
See all related articles

Related Experiment Video

Updated: Feb 11, 2026

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
08:48

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis

Published on: July 11, 2025

637

Tuberculosis in the 1990s

J B Bass1

  • 1Division of Pulmonary and Critical Care Medicine, University of South Alabama Medical Center, Mobile 36617, USA.

Alcoholism, Clinical and Experimental Research
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

The tuberculosis (TB) case rate reversed its decline in the 1980s, with significant increases driven by the human immunodeficiency virus (HIV) epidemic and foreign-born populations. This resurgence includes drug-resistant TB strains, necessitating updated treatment strategies.

More Related Videos

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.8K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.6K

Related Experiment Videos

Last Updated: Feb 11, 2026

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
08:48

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis

Published on: July 11, 2025

637
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.8K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.6K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • The tuberculosis (TB) case rate experienced a steady decline until the mid-1980s, after which it began to increase dramatically.
  • Key factors contributing to this resurgence include the human immunodeficiency virus (HIV) epidemic and the prevalence of TB in foreign-born individuals.
  • Outbreaks of TB have been documented in various settings, including HIV clinics, correctional facilities, homeless shelters, nursing homes, and healthcare settings.

Purpose of the Study:

  • To highlight the reversal of the declining tuberculosis case rate since the mid-1980s.
  • To identify the primary drivers of the recent increase in tuberculosis cases.
  • To underscore the emergence of multidrug-resistant tuberculosis strains and the need for revised therapeutic approaches.

Main Methods:

  • Analysis of tuberculosis case rate trends.
  • Identification of contributing factors such as the HIV epidemic and foreign-born populations.
  • Documentation of tuberculosis outbreak locations and characteristics, including drug resistance patterns.

Main Results:

  • The tuberculosis case rate reversed its long-term decline in the mid-1980s.
  • Significant increases in TB cases are linked to the HIV epidemic and foreign-born individuals.
  • Outbreaks of multidrug-resistant tuberculosis have occurred in high-risk congregate settings.

Conclusions:

  • The resurgence of tuberculosis, exacerbated by HIV and immigration, poses a significant public health challenge.
  • The emergence of multidrug-resistant TB necessitates urgent attention and revised treatment protocols.
  • Current recommendations emphasize four-drug therapy and directly observed therapy to combat drug resistance and improve patient outcomes.